| 000 | 01339 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517114615.0 | ||
| 264 | 0 | _c20180105 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.13132 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeyvanjah, Kiana | |
| 245 | 0 | 0 |
_aPharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _c03 2017 |
||
| 300 |
_a554-561 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLansoprazole _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aProton Pump Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aQuinolines _xadverse effects |
| 700 | 1 | _aDiPrimeo, Daniel | |
| 700 | 1 | _aLi, Ai | |
| 700 | 1 | _aObaidi, Mohammad | |
| 700 | 1 | _aSwearingen, Dennis | |
| 700 | 1 | _aWong, Alvin | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 83 _gno. 3 _gp. 554-561 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.13132 _zAvailable from publisher's website |
| 999 |
_c26419030 _d26419030 |
||